Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,939 articles
Appleton Partners Inc. MA Lowers Position in AbbVie Inc. $ABBV
Appleton Partners Inc. MA decreased its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 11.1% in the fourth quarter, according to...
Intuitive Surgical, Inc. $ISRG is Assenagon Asset Management S.A.’s 10th Largest Position
Assenagon Asset Management S.A. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 106.6% during the 4th...
📰
Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally
This RNA therapeutics innovator for rare diseases reported a notable insider sale amid a year of dramatic share price gains.
MoonLake Immunotherapeutics (NASDAQ:MLTX) Upgraded to “Outperform” at Wolfe Research
Wolfe Research upgraded shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) from an underperform rating to an outperform rating...
Ericsson's Vonage, ServiceNow Deepen Partnership To Transform Customer Support
Vonage, part of Ericsson (NASDAQ:ERIC), expanded its partnership with ServiceNow, Inc. (NYSE:NOW) to embed voice and real-time AI into enterprise...
What's Behind The Jump In ENvue Medical Stock Today?
Shares of ENvue Medical, Inc. (NASDAQ:FEED) are surging on Tuesday after the company disclosed a new hospital system win that lifts its U.S....
📰
Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF
After nearly tripling between 2023 and the end of 2025, Lilly is undergoing a steep sell-off in 2026.
GSK (NYSE:GSK) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?
Shares of GSK PLC Sponsored ADR (NYSE:GSK – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a...
Pediatrix Medical Group (NYSE:MD) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report)’s stock price passed above its two hundred day moving average during trading on...
LeMaitre Vascular (NASDAQ:LMAT) Stock Passes Above 200-Day Moving Average – What’s Next?
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on...
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of “Moderate Buy” by Brokerages
Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the...
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of “Reduce” by Brokerages
Shares of Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) have earned a consensus rating of “Reduce” from the ten...
Biogen Inc. (NASDAQ:BIIB) Given Average Recommendation of “Hold” by Analysts
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus rating of “Hold” from the twenty-eight...
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) has received a consensus rating of “Moderate Buy” from the twelve analysts...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the...
Becton, Dickinson and Company (NYSE:BDX) Price Target Cut to $180.00 by Analysts at Argus
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price objective decreased by Argus from $230.00 to $180.00 in a research note...
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Hold” by Brokerages
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received an average recommendation of “Hold” from the...
Here's Why You Should Retain GEHC Stock in Your Portfolio for Now
GE HealthCare rides a strong backlog, innovation and diagnostics growth, but tariffs and margin pressures threaten to temper its forward momentum.
Here's Why You Should Retain GEHC Stock in Your Portfolio for Now
GE HealthCare rides a strong backlog, innovation and diagnostics growth, but tariffs and margin pressures threaten to temper its forward momentum.
Here's Why You Should Retain GEHC Stock in Your Portfolio for Now
GE HealthCare rides a strong backlog, innovation and diagnostics growth, but tariffs and margin pressures threaten to temper its forward momentum.
Here's Why You Should Retain GEHC Stock in Your Portfolio for Now
GE HealthCare rides a strong backlog, innovation and diagnostics growth, but tariffs and margin pressures threaten to temper its forward momentum.
BioHarvest Sciences (NASDAQ:BHST) Trading 0.9% Higher – Still a Buy?
Shares of BioHarvest Sciences Inc. (NASDAQ:BHST – Get Free Report) were up 0.9% during trading on Monday . The company traded as high as $4.40...
Citius Oncology (NASDAQ:CTOR) Trading Down 2.8% – Here’s What Happened
Citius Oncology, Inc. (NASDAQ:CTOR – Get Free Report) fell 2.8% during trading on Monday . The stock traded as low as $0.62 and last traded at...
📰
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
Medicare Advantage specialist Alignment Healthcare reported a notable insider sale as its leadership continues to adjust personal holdings.
Danaher Corporation (NYSE:DHR) Given Consensus Rating of “Moderate Buy” by Brokerages
Danaher Corporation (NYSE:DHR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-two...
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Rating of “Moderate Buy” from Analysts
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen...
Medtronic PLC (NYSE:MDT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Medtronic PLC (NYSE:MDT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the...
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Valneva plunges 37% as Lyme vaccine study shows 70%+ efficacy but misses key statistical target, raising concerns despite plans for regulatory...
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Valneva plunges 37% as Lyme vaccine study shows 70%+ efficacy but misses key statistical target, raising concerns despite plans for regulatory...
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Valneva plunges 37% as Lyme vaccine study shows 70%+ efficacy but misses key statistical target, raising concerns despite plans for regulatory...
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Valneva plunges 37% as Lyme vaccine study shows 70%+ efficacy but misses key statistical target, raising concerns despite plans for regulatory...
Vertiv Ramps Up Capacity To Feed Surging AI Data Center Frenzy
Vertiv Holdings Co. (NYSE:VRT) announced plans to expand its manufacturing footprint in the Americas. The move aims to increase capacity for AI and...
Brokerages Set NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Target Price at $48.00
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Receives $5.40 Consensus Price Target from Brokerages
Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) have been assigned an average recommendation of “Moderate Buy”...
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives $46.09 Consensus PT from Analysts
Capricor Therapeutics, Inc. (NASDAQ:CAPR – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the...
Immunome, Inc. (NASDAQ:IMNM) Receives $33.45 Average Target Price from Brokerages
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven analysts...
NanoViricides (NYSE:NNVC) Stock Price Down 4.8% – What’s Next?
NanoViricides, Inc. (NYSE:NNVC – Get Free Report)’s stock price dropped 4.8% during mid-day trading on Monday . The stock traded as low...
BriaCell Therapeutics (TSE:BCT) Shares Up 2.8% – Still a Buy?
BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report)’s stock price shot up 2.8% during mid-day trading on Monday . The company traded...
-logo-1200x675.png){kind=logo}
Swedencare AB (publ) (OTCMKTS:SWDCF) Stock Price Down 1% – Time to Sell?
Shares of Swedencare AB (publ) (OTCMKTS:SWDCF – Get Free Report) fell 1% during trading on Monday . The stock traded as low as C$2.75 and last...
Theriva Biologics (NYSEAMERICAN:TOVX) Trading 8.4% Higher – Here’s What Happened
Theriva Biologics, Inc. (NYSEAMERICAN:TOVX – Get Free Report) shares traded up 8.4% during mid-day trading on Monday . The stock traded as high...
Coeptis Therapeutics (NASDAQ:COEP) Trading Down 2.1% – Here’s What Happened
Shares of Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP – Get Free Report) were down 2.1% on Monday . The stock traded as low as $10.85 and...
📰
Deadline Alert: Picard Medical, Inc. (PMI) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 24, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 3, 2026 deadline to...
Pluri (NASDAQ:PLUR) Trading Down 1.6% – Here’s What Happened
Pluri Inc. (NASDAQ:PLUR – Get Free Report)’s stock price was down 1.6% during mid-day trading on Monday . The company traded as low as...
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 2.4% – What’s Next?
Shares of Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Free Report) dropped 2.4% on Monday . The stock traded as low as $1.98 and last traded...
LifeMD (NASDAQ:LFMDP) Shares Up 0.1% – Time to Buy?
LifeMD, Inc. (NASDAQ:LFMDP – Get Free Report)’s share price traded up 0.1% during mid-day trading on Monday . The stock traded as high as...
This SAP Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...